Company Page

Strand AI provides curated multimodal datasets and data tools for biological research and AI applications. The company addresses the challenge that acquiring every modality for every patient is expensive, invasive, and often impossible in clinical trials. Strand AI enables life sciences teams to generate missing modalities to recover insights from incomplete cohorts, predict proteomic or transcriptomic profiles from routinely collected data like pathology slides, and synthesize data types for rare disease research. The platform helps biotech companies reduce assay costs, prioritize candidates before expensive validation, and impute unmeasured molecular markers across entire cohorts to surface predictive signatures.

Company Founded in 2025

Healthtech & Biotech

Articles about Strand AI

AI Models Predict Missing Biology Data to Speed Drug Discovery

Healthtech & BiotechMar 25, 2026

Strand AI Predicts Missing Biology Data With Foundation Models

Healthtech & BiotechMar 16, 2026

Strand AI Launches Models to Predict Missing Biology Data for Drug Trials

Healthtech & BiotechMar 14, 2026

How AI Foundation Models Are Solving Biology's Missing Data Problem

Healthtech & BiotechMar 6, 2026

Foundation Models Race to Fill Biology's Data Gaps

Healthtech & BiotechMar 4, 2026

Strand AI Launches Foundation Models to Fill Gaps in Biological Data

Healthtech & BiotechFeb 21, 2026